Tuesday, September 27, 2016

Color Genomics Captures $45M For Genetic Testing For Cancer Risk

Burlingame-basd Color, a company which offers up genetic testing for cancer risk to the general public, has raised $45M in a Series B funding. The funding was led by General Catalyst, and also included U2's Bono, along with Susan L. Wagner, 8VC, Khosla Ventures and Emerson Collective. As part of the funding, Susan Wagner (formerly of BlackRock) and Hemant Taneja (General Catalyst) both join the company's board. Color is led by Elad Gil. More information »